Precision drugs and gene therapy treatments to activate pro-survival pathways in selected neuronal populations

We investigate molecular mechanisms promoting functional maintenance of dopaminergic neurons, a neuronal population predominantly affected in Parkinson’s disease patients. We are aiming to find novel drugs and therapeutic strategies to support survival of dopaminergic neurons and protect them from cellular stress and pathological protein aggregation.
@ADom_Lab

Missed @NeuronlineSfN's webinar on non-coding (nc)RNAs? Register to watch panelist's conversation on-demand as th… twitter.com/i/web/status/1…

Our next alpha-synuclein paper is out! Great work Irena, and great idea @valimaki_mika. I am very happy about the c… twitter.com/i/web/status/1…

Interesting - new report from @katecholamine @airavaara & @HiLIFE_helsinki colleagues finds that Cerebral dopamine… twitter.com/i/web/status/1…

April 11 is #WorldParkinsonsDay, a time to raise awareness and to unite toward a shared goal: stopping #Parkinsonstwitter.com/i/web/status/1…

Recent publications

RSS Feed

No results.